Minolira Extended Release (Page 6 of 6)
INSTRUCTIONS FOR USE MINOLIRA (min-oh-li’-rah) (minocycline hydrochloride) extended-release tablets
Read this Instructions for Use before you start using MINOLIRA and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.
Note:
- Your healthcare provider will tell you how much of MINOLIRA to take and if you will need to break MINOLIRA extended-release tablets based on your weight.
- MINOLIRA comes in 2 strengths:
- 105 mg extended-release tablets
- 135 mg extended-release tablets
The 105 mg MINOLIRA tablets:
- are marked with an “M” and “1” on one side and is separated by a scored line
- can be taken whole or may be broken at the scored line to provide two equal halves of 52.5 mg each
How to break your MINOLIRA tablets?
- Hold the tablet between your thumbs and index fingers close to the scored line.
- Apply enough pressure to break the tablet at the scored line.
- Do not break the MINOLIRA tablet in any other way.
- 105 mg treatment (take whole tablet)
top view of whole tablet | side view of whole tablet | side view of whole tablet with thumbs and index fingers |
- 52.5 mg treatment (take one-half of the tablet)
side view of breaking a whole tablet with thumbs and index fingers | top view of a split tablet | side view of one-half tablet with a thumb and an index finger |
The 135 mg MINOLIRA tablets:
- are marked with an “M” and “3” on one side and is separated by a scored line
- can be taken whole or may be broken at the scored line to provide two equal halves of 67.5 mg each
How to break your MINOLIRA tablets?
- Hold the tablet between your thumbs and index fingers close to the scored line.
- Apply enough pressure to break the tablet at the scored line.
- Do not break the MINOLIRA tablet in any other way.
- 135 mg treatment (take whole tablet)
top view of whole tablet | side view of whole tablet | side view of whole tablet with thumbs and index fingers |
- 67.5 mg treatment (take one-half of the tablet)
side view of breaking a whole tablet with thumbs and index fingers | top view of a split tablet | side view of one-half tablet with a thumb and an index finger |
How should I store MINOLIRA?
- Store MINOLIRA at room temperature between 68°F to 77°F (20°C to 25°C).
- Keep MINOLIRA in the container that it comes in and keep the container tightly closed.
- Keep MINOLIRA away from light and moisture.
Keep MINOLIRA and all medicines out of the reach of children.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Manufactured for:
EPI Health, LLC
134 Columbus St.
Charleston, SC 29403, USA
Manufactured by:
Dr. Reddy’s Laboratories Limited
FTO-SEZ, Process Unit-01,
Devunipalavalasa Village, Srikakulam (District),
Andhra Pradesh, India.
Pin-:532409
MINOLIRA is a registered trademark of EPI Health, LLC
Item No. MIN-PI-0618/150073673
Issued: 06/2018
PRINCIPAL DISPLAY PANEL — 135 mg Tablet Bottle Label
NDC 71403-102-30
Rx Only
minolira™
(minocycline hydrochloride)
extended-release tablets
135 mg*
*Each tablet contains 135 mg of minocycline
(33.75 mg as immediate release beads and
101.25 mg as extended release beads), equivalent
to 145.8 mg of minocycline hydrochloride.
30 Tablets
EPIHEALTH Advancing Dermatology
PRINCIPAL DISPLAY PANEL — 105 mg Tablet Bottle Label
NDC 71403-101-30
Rx Only
minolira™
(minocycline hydrochloride)
extended-release tablets
105 mg*
*Each tablet contains 105 mg of minocycline
(26.25 mg as immediate release beads and 78.75
mg as extended release beads), equivalent to
113.4 mg of minocycline hydrochloride.
30 Tablets
EPIHEALTH Advancing Dermatology
MINOLIRA EXTENDED RELEASE minocycline hydrochloride tablet | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
MINOLIRA EXTENDED RELEASE minocycline hydrochloride tablet | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
Labeler — EPI Health, Inc (080638894) |
Establishment | |||
Name | Address | ID/FEI | Operations |
EPI Health, Inc. | 080638894 | MANUFACTURE (71403-102), MANUFACTURE (71403-101) |
Revised: 11/2022 EPI Health, Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/minolira-extended-release/page/6/